Cadrenal Therapeutics, Inc. Quarterly Current Ratio in % from Q3 2023 to Q3 2024

Taxonomy & unit
ratio: %
Description
The current ratio is a liquidity ratio that measures a company's ability to cover its short-term obligations with its current assets.
Summary
Cadrenal Therapeutics, Inc. quarterly Current Ratio history and growth rate from Q3 2023 to Q3 2024.
  • Cadrenal Therapeutics, Inc. Current Ratio for the quarter ending September 30, 2024 was 581 %, a 13.6% decline year-over-year.
Current Ratio, Quarterly (%)
Current Ratio, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date
Q3 2024 581 -91.2 -13.6% Sep 30, 2024
Q2 2024 815 Jun 30, 2024
Q1 2024 1.08K Mar 31, 2024
Q4 2023 1.19K Dec 31, 2023
Q3 2023 672 Sep 30, 2023
* An asterisk sign (*) next to the value indicates that the value is likely invalid.